PFF Summit

November 17, 2017November 17, 2017

Veracyte’s Genomic Tool Aids in Diagnosing IPF Without Surgery, Real-world Data Suggests

Veracyte presented early data from a real-world clinical test showing that its Envisia Genomic Classifier is an efficient tool for diagnosing idiopathic pulmonary fibrosis (IPF) without invasive and expensive surgery. ... Read more

November 16, 2017November 16, 2017

Ofev Slows Scarring in Pulmonary Fibrosis Patients’ Lungs, Phase 3b Trial Shows

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim’s Ofev (nintedanib) slows scarring in idiopathic pulmonary fibrosis patients’ lungs, a Phase 3b trial indicates. The company used an imaging technique to check on Ofev’s anti-fibrotic properties. It was the ... Read more